These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 30318356)
1. Role of vitamin D deficiency as a risk factor for infections in cirrhotic patients. Ramadan HK; Makhlouf NA; Mahmoud AA; Abd Elrhman M; El-Masry MA Clin Res Hepatol Gastroenterol; 2019 Feb; 43(1):51-57. PubMed ID: 30318356 [TBL] [Abstract][Full Text] [Related]
2. Associated vitamin D deficiency is a risk factor for the complication of HCV-related liver cirrhosis including hepatic encephalopathy and spontaneous bacterial peritonitis. Yousif MM; Sadek AMEM; Farrag HA; Selim FO; Hamed EF; Salama RI Intern Emerg Med; 2019 Aug; 14(5):753-761. PubMed ID: 30706253 [TBL] [Abstract][Full Text] [Related]
3. Association between serum vitamin D status and severity of liver cirrhosis: implications for therapeutic targeting in Nigerian patients. Adiri WN; Basil B; Onyia CP; Asogwa P; Ugwuanyi OJ; Obienu O; Ijoma UN; Nwokediuko SC BMC Gastroenterol; 2024 Aug; 24(1):259. PubMed ID: 39135191 [TBL] [Abstract][Full Text] [Related]
4. Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis. Buonomo AR; Zappulo E; Scotto R; Pinchera B; Perruolo G; Formisano P; Borgia G; Gentile I Int J Infect Dis; 2017 Oct; 63():23-29. PubMed ID: 28804006 [TBL] [Abstract][Full Text] [Related]
5. Is Serum-Ascites Vitamin D Gradient a Valid Marker for Diagnosing Spontaneous Bacterial Peritonitis in Patients with Cirrhotic Ascites? Abdel Hafez H; Madani H; Abdel Alem S; Farrag A; Fathy W; Abdo M Lab Med; 2021 Nov; 52(6):567-573. PubMed ID: 33939819 [TBL] [Abstract][Full Text] [Related]
6. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Monegal A; Navasa M; Guañabens N; Peris P; Pons F; Martinez de Osaba MJ; Rimola A; Rodés J; Muñoz-Gómez J Calcif Tissue Int; 1997 Feb; 60(2):148-54. PubMed ID: 9056162 [TBL] [Abstract][Full Text] [Related]
7. Enhanced LL-37 expression following vitamin D supplementation in patients with cirrhosis and spontaneous bacterial peritonitis. Zhang C; Zhao L; Ding Y; Sheng Q; Bai H; An Z; Xia T; Wang J; Dou X Liver Int; 2016 Jan; 36(1):68-75. PubMed ID: 26058412 [TBL] [Abstract][Full Text] [Related]
8. Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study. Mohamed AA; Al-Karmalawy AA; El-Kholy AA; El-Damas DA; Abostate HM; Mostafa SM; Hamada M; Khalik Elkady MA; Hassan Y; Al-Hussain E; Khalil MG; Badawy I; Elebeedy D; Alsfouk BA; Shaheenl MM Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):6908-6919. PubMed ID: 34859852 [TBL] [Abstract][Full Text] [Related]
9. Low 25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosis. Paternostro R; Wagner D; Reiberger T; Mandorfer M; Schwarzer R; Ferlitsch M; Trauner M; Peck-Radosavljevic M; Ferlitsch A Wien Klin Wochenschr; 2017 Jan; 129(1-2):8-15. PubMed ID: 27888359 [TBL] [Abstract][Full Text] [Related]
10. Association of low serum 25-Hydroxy vitamin D [25(OH) d] with hepatic encephalopathy in patients with decompensated liver cirrhosis. Mumit Sarkar A; Al Mukit A; Bari T; Islam R; Islam S; Sarker K; Chowdhury M; Harun Or Rashid M; Alim A Arab J Gastroenterol; 2024 May; 25(2):182-187. PubMed ID: 38458876 [TBL] [Abstract][Full Text] [Related]
11. Vitamin D deficiency is associated with hepatic decompensation and inflammation in patients with liver cirrhosis: A prospective cohort study. Kubesch A; Quenstedt L; Saleh M; Rüschenbaum S; Schwarzkopf K; Martinez Y; Welsch C; Zeuzem S; Welzel TM; Lange CM PLoS One; 2018; 13(11):e0207162. PubMed ID: 30408125 [TBL] [Abstract][Full Text] [Related]
12. Low Levels of 25-Hydroxy Vitamin D are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients. Anty R; Tonohouan M; Ferrari-Panaia P; Piche T; Pariente A; Anstee QM; Gual P; Tran A Clin Transl Gastroenterol; 2014 May; 5(5):e56. PubMed ID: 24871371 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D status in patients with cirrhosis of the liver and their relatives-A case control study from North India. Kumar R; Kumar P; Saxena KN; Mishra M; Mishra VK; Kumari A; Dwivedi M; Misra SP Indian J Gastroenterol; 2017 Jan; 36(1):50-55. PubMed ID: 28176238 [TBL] [Abstract][Full Text] [Related]
14. Hepatic Decompensation in Patients with Chronic Liver Disease: Exploring the Role of Vitamin D Deficiency as a Prognostic Marker. Nilajkar GM; Kolwalkar RJ; Prithvi KA J Assoc Physicians India; 2024 Mar; 72(3):82-86. PubMed ID: 38736123 [TBL] [Abstract][Full Text] [Related]
15. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease. Trépo E; Ouziel R; Pradat P; Momozawa Y; Quertinmont E; Gervy C; Gustot T; Degré D; Vercruysse V; Deltenre P; Verset L; Gulbis B; Franchimont D; Devière J; Lemmers A; Moreno C J Hepatol; 2013 Aug; 59(2):344-50. PubMed ID: 23557869 [TBL] [Abstract][Full Text] [Related]
16. Vitamin D deficiency is associated with increased risk of bacterial infections after kidney transplantation. Park YJ; Kim SU; Lee KH; Lee JH; Kwon E; Jung HY; Choi JY; Cho JH; Park SH; Kim YL; Kim HK; Huh S; Kim CD Korean J Intern Med; 2017 May; 32(3):505-513. PubMed ID: 27017390 [TBL] [Abstract][Full Text] [Related]
17. Vitamin D deficiency is associated with mortality in patients with advanced liver cirrhosis. Stokes CS; Krawczyk M; Reichel C; Lammert F; Grünhage F Eur J Clin Invest; 2014 Feb; 44(2):176-83. PubMed ID: 24236541 [TBL] [Abstract][Full Text] [Related]
18. Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease. Putz-Bankuti C; Pilz S; Stojakovic T; Scharnagl H; Pieber TR; Trauner M; Obermayer-Pietsch B; Stauber RE Liver Int; 2012 May; 32(5):845-51. PubMed ID: 22222013 [TBL] [Abstract][Full Text] [Related]
19. Spontaneous ascitic infection in different cirrhotic groups: prevalence, risk factors and the efficacy of cefotaxime therapy. Kaymakoglu S; Eraksoy H; Okten A; Demir K; Calangu S; Cakaloglu Y; Boztas G; Besisik F Eur J Gastroenterol Hepatol; 1997 Jan; 9(1):71-6. PubMed ID: 9031903 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of fat-soluble vitamin (A, D, and E) and zinc deficiency in patients with cirrhosis being assessed for liver transplantation. Teriaky A; Mosli M; Chandok N; Al-Judaibi B; Marotta P; Qumosani K Acta Gastroenterol Belg; 2017; 80(2):237-241. PubMed ID: 29560688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]